Neuland Laboratories Limited (NEULANDLAB.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-81.6%

₹3,582.73

vs ₹19,422.00 price

Levered DCF

₹10,318.21

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

—

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	42.39×	56.64×	26.79×	14.15×	20.69×	33.24×	22.4×	50.38×
P/B	8.23×	9.66×	6.27×	2.33×	1.57×	3.41×	0.51×	1.18×
P/S	7.63×	10.27×	5.3×	1.99×	1.43×	2.92×	0.49×	1.26×
EV / EBITDA	25.89×	35.34×	17.04×	8.6×	11.05×	18.12×	6.13×	18.74×
Gross margin	31.8%	47.7%	51.6%	47.1%	40.1%	39.6%	45.3%	38.6%
Operating margin	23.9%	18.6%	26.9%	20.2%	10.4%	11.9%	10.0%	5.8%
Net margin	18.0%	18.1%	19.8%	14.1%	6.9%	8.8%	2.2%	2.5%
Current ratio	2.09×	2.45×	2.15×	1.73×	1.6×	1.49×	1.44×	1.39×
Debt / equity	0.16×	0.1×	0.07×	0.13×	0.29×	0.23×	0.37×	0.33×
Interest coverage	20.16×	32.13×	29.1×	17.93×	7.12×	6.13×	3.41×	2.45×
Dividend yield	0.1%	0.1%	0.2%	0.3%	0.3%	0.1%	1.4%	0.0%
Payout ratio	4.2%	6.9%	4.3%	3.9%	6.0%	3.2%	30.5%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	19.4%	17.1%	23.4%	16.4%	7.6%	10.3%	2.3%	2.4%
Return on invested capital	15.9%	11.4%	21.1%	14.9%	6.5%	8.1%	2.1%	3.2%
Return on assets	12.4%	11.9%	16.4%	10.4%	4.6%	6.1%	1.3%	1.5%
Free cash flow yield	-0.4%	0.8%	1.5%	7.4%	-2.8%	3.1%	2.4%	0.8%
Earnings yield	2.4%	1.8%	3.7%	7.1%	4.8%	3.0%	4.5%	2.0%
Enterprise value	₹156.6B	₹147.6B	₹80.5B	₹24B	₹15.6B	₹28.6B	₹6.2B	₹10.5B
Net debt / EBITDA	0.37×	0.06×	0.02×	0.3×	1.67×	1.14×	2.52×	3.98×
Cash conversion cycle (days)	161	145	171	181	192	151	193	164